ID   WAe001-A-20
AC   CVCL_UD91
SY   H1-GLI3-KO; GIBHe007-A-20
DR   hPSCreg; WAe001-A-20
DR   Wikidata; Q98134684
RX   PubMed=30278376;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 4319; GLI3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=30278376
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 13,15
ST   D21S11: 28,32.2
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
RX   PubMed=30278376; DOI=10.1016/j.scr.2018.09.010;
RA   Wei R.-Z., Yuan F., Wu Y.-H., Liu Y.-L., You K., Yang Z., Chen Y.,
RA   Getachew A., Wang N., Xu Y.-Y., Zhuang Y.-Q., Yang F., Li Y.-X.;
RT   "Construction of a GLI3 compound heterozygous knockout human embryonic
RT   stem cell line WAe001-A-20 by CRISPR/Cas9 editing.";
RL   Stem Cell Res. 32:139-144(2018).
//